Challenges Remain in Treating Anaplastic Thyroid Cancer
Yuliya Mikheeva, MD, PhD, discusses the many challenges oncologists face in treating patients with anaplastic thyroid cancer harboring BRAF mutations.
Design of the ANAPLAST-NEO Study for Anaplastic Thyroid Cancer
Yuliya Mikheeva, MD, PhD, discusses the design of the phase 2 ANAPLAST-NEO study
BRAF/MEK Combo Might Increase Survival in Patients With Anaplastic Thyroid Cancer
Yuliya Mikheeva, MD, discusses the phase 2 ANAPLAST-NEO study for patients with anaplastic thyroid cancer.